TPST (tempesttx.com) Kacepetan wutah bathi saben saham ing taun lumaku
The annual EPS percentage difference demonstrates profit dynamics, where the current metric is 54.50. The absence of recurring revenue is driven by Tempest Therapeutics (TPST) focusing on clinical trials for targeted therapy. Developments in treating liver cancer via immune response confirm the growth stage. Meanwhile, competent management effectively attracts venture capital, ensuring high transparency in pipeline reporting.
Rincian analitis lan laporan data perusahaan Tempest Therapeutics (TPST)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Tempest Therapeutics|TPST - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas tempesttx.com|TPST - Gunggung utang perusahaan|Utang-utang marang nilai buku Tempest Therapeutics Corp|TPST - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Tempest Therapeutics|Rasio likuiditas perantara tempesttx.com
- indikator bathi lan kelipatan valuasi:
TPST - Penghasilan resik|Penghasilan resik sing dikarepake Tempest Therapeutics|TPST - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Tempest Therapeutics Corp|TPST - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Tempest Therapeutics Corp|TPST - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Tempest Therapeutics|TPST - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan tempesttx.com|TPST - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Tempest Therapeutics
Pambiji fundamental:TPST Tempest Therapeutics Inc
For the biotechnology startup Tempest Therapeutics (TPST), which develops targeted oncology therapies, this indicator serves as a measure of the efficiency of innovation capitalization. The metric calculates the percentage deviation of current earnings per share from the same value last year. Analyzing the YoY net income per share trend allows for tracking the company's pace of financial transformation. Growth in this figure confirms the success of drug commercialization, while negative trends signal high R&D expenditures.
Pesaing utama
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi resik saben saham ing taun iki AAPG (Ascentage Pharma Group)|Wutah bathi resik saben siji saham kanggo taun lumaku CGON|Wutah bathi ing taun lumaku URGN (UroGen Pharma)|Bicara Therapeutics Inc (BCAX) - Kacepetan wutah bathi saben saham ing taun lumaku|PSNL - Wutah bathi saben saham ing taun lumaku|Erasca Oncology (ERAS) - Wutah bathi resik saben saham ing taun iki|Delcath Systems, Inc. (DCTH) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku YMAB (ymabs.com)|AURA (Aura Biosciences) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Candel CADL|Wutah bathi saben saham ing taun lumaku Accuray Inc. (ARAY)|Prakiraan wutah bathi resik saben saham ing taun iki sellaslifesciences.com|Actuate Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CTOR (citiusonc.com)|HURA: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics Inc)|FATE (Fate Therapeutics Corp) - Wutah bathi resik saben saham ing taun iki|WHWK: Wutah bathi resik saben siji saham kanggo taun lumaku|TCRX (TScan Therapeutics Inc) - Wutah bathi ing taun lumaku|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku XBIT|CVM - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku OS Therapies Inc OSTX|Tambahing bathi saben saham ing taun lumaku RADX|Artiva - Wutah bathi ing taun lumaku|ANL - Wutah bathi ing taun lumaku|Veru (VERU) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku XLO (Xilio Therapeutics)|RENB (Renovaro Biosciences) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Mural Bio MURA|Wutah bathi resik saben saham ing taun iki KAPA (Kairos Pharma Ltd)|Wutah bathi ing taun lumaku onkuretherapeutics.com (OKUR)|CytoMed Therapeutics Limited - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CRIS (Curis Inc.)|Apollomics Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Tharimmune Corporation THAR|ADVB: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki genprex.com|Wutah bathi saben saham ing taun lumaku Calidi Biotherapeutics Inc.|sunshinebiopharma.com (SBFM) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki XBIO (Xenetic Biosciences)|Wutah bathi resik saben siji saham kanggo taun lumaku SLRX|Wutah bathi saben saham ing taun lumaku Purple Biotech PPBT|AONC (American Oncology Network Inc) - Dinamika bathi saben saham ing taun lumaku|BGNE - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Checkpoint Therapeutics Inc. CKPT|ELEV (Elevation Oncology) - Wutah bathi resik saben saham ing taun iki|ICAD: Wutah bathi resik saben siji saham kanggo taun lumaku|IKNA (Ikena Oncology Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki notablelabs.com (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi ing taun lumaku MorphoSys Inc (MOR)|Wutah bathi saben saham ing taun lumaku NAYA Bio NAYA|AAPGV: Wutah bathi saben saham ing taun iki
